TCM Ltd Announces AGM and Annual Report for FY26

TCM Ltd has announced its Annual General Meeting (AGM) scheduled for Friday, 25th September 2026. The company is enclosing the Notice of the AGM along with the Annual Report for the Financial Year 2025-2026, as per Regulation 34. The annual report highlights the company's product range, including advanced diagnostic solutions like Fluorescreen FIA-101 POCT Immuno Assay, Fluorecare MF-T1000 POCT Platform, Tesmi-i50 Neo, Portable Immune Analyzer WIZ-TCM IA-101, and Fully Automated Urinalysis Hybrid. These products are designed for rapid, accurate testing in point-of-care and laboratory settings. The filing also lists the company's directors, managing director, company secretary, CFO, statutory auditors, secretarial auditors, internal auditors, registered office details, share transfer agents, and bankers.